Last reviewed · How we verify
Celexa
At a glance
| Generic name | Celexa |
|---|---|
| Sponsor | University of Ottawa |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Boxed warnings
- WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short -term studies . Closely m onitor all antidepressant-treated patients for clinical worsening , and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions ( 5.1 )] . CELEXA is not approved for use in pediatric patients [see Use in Specific Populations ( 8.4 )]. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescrib
Common side effects
- Ejaculation disorder (primarily ejaculatory delay)
- Nausea
- Somnolence
- Insomnia
- Fatigue
- Impotence
- Increased sweating
- Yawning
- Sexual dysfunction
Key clinical trials
- Dynamic Networks in Depression Treatment: Mechanisms of Change in Pharmacological, Psychological and Combined Treatment of Depression (PHASE4)
- TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children (PHASE4)
- Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder (NA)
- Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease (PHASE2)
- Acupuncture and Escitalopram for Treating Major Depression Clinical Study (NA)
- Pattern Separation in Major Depressive Disorder (PHASE1)
- Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D) (PHASE4)
- Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Celexa CI brief — competitive landscape report
- Celexa updates RSS · CI watch RSS
- University of Ottawa portfolio CI